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ABSTRACT OF THE THESIS
CHARACTERIZATION OF ENGINEERED HUMAN LUNG TISSUE
by
Benjamin Boytor
Florida International University, 2002
Miami, Florida
Professor Eric T. Crumpler, Major Professor
Characterizing engineered human lung tissue is an important step in developing a
functional tissue replacement for lung tissue repair and in vitro analysis. Small tissue
constructs were grown by seeding IMR-90 fetal lung fibroblasts and adult microvascular
endothelial cells onto a Polyglycolic acid (PGA) polymer template. Introducing the
constructs to dynamic culture conditions inside a bioreactor facilitated three-dimensional
growth seen in scanning electron microscopy images (SEM).
Characterization of the resultant tissue samples was done using SEM imagery, tensile
tests, and biochemical assays to quantify extra-cellular matrix (ECM) composition.
Tensile tests of the engineered samples indicated an increase in the mechanical properties
when compared with blank constructs. Elastin and collagen content was found to average
3.19% and 15.49% respectively in relation to total mass of the tissue samples. The
presence of elastin and collagen within the constructs most likely explains the mechanical
differences that we noted.
These findings suggest that the necessary ECM can be established in engineered tissue
constructs and that optimization of this procedure has the capacity to generate the load
bearing elements required for construction of a functional lung tissue equivalent.
v
TABLE OF CONTENTS
CHAPTER PAGE
1. STATEMENT OF PROBLEM...............................................................1
2. INTRODUCTION...........................................................................3
3. SIGNIFICANCE AND BACKGROUND...................................................6
4. METHODOLOGY AND MATERIALS....................................................15
4.1 Cell Seeding of Polymer Scaffolds................................................15
4.2 Tensile Test Protocol................................................................18
4.3 SEM Imagery.........................................................................18
4.4 Biochemical Analysis...............................................................18
4.5 Materials..............................................................................19
4.5.1 Human Microvascular Endothelial Lung Cells (HMVELC)........19
4.5.2 EGM-2 Growth Media for HMVELC.................................19
4.5.3 Human Fetal Lung Fibroblasts (IMR-90).............................19
4.5.4 EMEM Supplemented Growth Media for IMR-90 cells............20
4.5.5 Bioreactors.................................................................20
4.5.6 PGA Polymer Scaffolding...............................................20
4.5.7 Analytical Assays.........................................................20
5. RESULTS.........................................................................................22
6. DISCUSSION....................................................................................42
7. CONCLUSION...................................................................................47
R E FE R E N C E S ...................................................................................... 49
APPENDICES ..................................................................................... 52
vi
LIST OF FIGURES
FIGURE PAGE
1.1 SEM of 3-day blank polymer................................................................22
1.2 SEM of 7-day blank polymer................................................................23
1.3 SEM of 7-day blank polymer................................................................23
2.1 Elastic modulus comparison of blank scaffolds............................................24
2.2 Yield Stress Comparison of blank scaffolds.................................................25
3.1 SEM of endothelial construct at 3-hours....................................................26
3.2 SEM of endothelial construct at 3-days......................................................27
3.3 SEM of endothelial construct at 3-days......................................................27
3.4 SEM of endothelial construct at 3-days ..................................................... 28
3.5 SEM of endothelial construct at 7-days.....................................................28
3.6 SEM of endothelial construct at 10-days...................................................29
4.1 Collagen standard for endothelial constructs...............................................30
4.2 Elastin standard for endothelial constructs.................................................30
5.1 SEM of fibroblast construct at 1-day........................................................31
5.2 SEM of fibroblast construct at 1-day........................................................31
5.3 SEM of fibroblast construct at 10-days.....................................................32
5.4 SEM of fibroblast construct at 10-days.....................................................33
5.5 SEM of fibroblast construct at 10-days.....................................................33
6.1 Elastic modulus of IMR-90 samples........................................................34
6.2 Yield stress of IMR-90 samples.............................................................34
vii
6.3 Yield strain of IMR-90 samples..............................................................35
6.4 Elastic modulus comparison..................................................................36
6.5 Yield stress comparison.......................................................................36
6.6 Yield strain comparison.......................................................................37
7.1 Elastin standard for IMR-90 constructs.....................................................38
7.2 Collagen standard for IMR-90 constructs...................................................38
7.3 Elastin and collagen content of batch 1.....................................................40
7.4 Elastin and collagen content of batch 2.....................................................40
7.5 Average elastin and collagen content.......................................................41
viii
LIST OF ACRONYMS
PGA Poly-glycolic acid
SEM Scanning electron microscopy
ECM Extra-cellular matrix
COPD Chronic obstructive pulmonary disease
LVRS Lung volume reduction surgery
3D Three dimensional
EGF Epidermal growth factor
TGF-a Transforming growth factor alpha
AR Amphiregulin
IGFs Insulin-like growth factors
FGFs Fibroblast growth factors
HGF Hepatocyte growth factor
PDGF Platelet-derived growth factor
TGF-(3 Transforming growth factor beta
GAGs Glycosaminoglycans
pO2 Partial oxygen
pCO2  Partial carbon dioxide
HARVs High aspect ratio vessels
DNA Deoxyribonucleic acid
HMVELC Human micro-vascular endothelial lung cells
RCCS Rotary cell culture system
EGM-2 MV Endothelial cell basal medium-2
ATCC American type culture collection
EMEM Eagle's minimal essential medium w/ Earle's BSS and 2mM L-glutamine
NEAA Non-essential amino acids
FBS Fetal bovine serum
ix
1. STATEMENT OF PROBLEM
This project approached the problem of mimicking the load-bearing
matrices associated with the gas-exchange barrier of the lung. The difficulty was in
the fact that this barrier is composed of numerous cell types with differing
functions. Initially one cell type was chosen, though future attempts may include co-
cultures or other cell types.
Two aspects were observed to be most important in addressing functionality:
ventilation and perfusion. Ventilation includes the expansion of the lung during
inspiration. In order for proper ventilation to occur, the tissue must exhibit the
ability to be elastic. Perfusion is the exchange of gases, particularly oxygen and
carbon dioxide, between the air and blood separated by the gas-exchange barrier.
Perfusion requires vascularization of the tissue for this process to occur.
Cell types that are included in the gas-exchange barrier were chosen for this
study. Endothelial cells and fibroblasts were studied because each of these cells is
thought to provide the necessary elements for elasticity and vascularization.
Endothelial cells provide the layer separating the capillaries from the alveolar walls
and may provide the necessary interface for angiogenesis. Fibroblasts, on the other
hand, are found within these walls and account for a majority of the elastic
framework. Both cell types were characterized for their contributions in re-creating
the gas-exchange barrier.
Experimental protocols followed an iterative process. Ultimately, we
described the tissue constructs both morphologically and mechanically. This initial
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characterization lead to further optimization of the tissue construct toward the end
result of a functional tissue equivalent.
2
2. INTRODUCTION
For the last decade, attention has been focused on the possibility of
engineering cell-derived functional replacements for numerous tissues within the
body. The majority of this tissue engineering research has focused on recreating
cartilage, bone, skin, and cardiac tissue equivalents. Because of early successes
within the field, research has come to include many other types of tissues. This
study has expanded on these early works and incorporated established techniques to
engineer lung tissue constructs, which were then evaluated for mechanical and
morphological properties associated with them.
By creating functional lung tissue equivalents, it can be possible to provide
treatments, through replacement patches, for patients inflicted with emphysema,
alpha-1 antitrypsin deficiency, or numerous other lung diseases in which there is an
associated loss of lung tissue functionality. Currently there are over 16 million
patients inflicted with chronic obstructive pulmonary disease (COPD) and this
disease is the fourth leading cause of death worldwide (National Heart, Lung, and
Blood Institute). In the cases of emphysema and chronic bronchitis, the walls
between the alveoli are damaged and a loss of lung tissue elasticity occurs. There
are no known cures for these types of diseases and treatment is only supportive.
One current treatment is lung volume reduction surgery (LVRS), which involves the
removal of a diseased region of lung tissue (National Heart, Lung, and Blood
Institute). Removal of the inflicted region within the lung only satisfies eliminating
the diseased area and not restoring lung functionality. The estimated direct and
indirect costs for this class of diseases reported for 2000 totaled nearly $30.4 billion
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(National Heart, Lung, and Blood Institute). Nine billion dollars accounted for
hospital costs and another $5.7 billion accounted for other direct costs (National
Heart, Lung, and Blood). Morbidity costs for 2000 were $6.5 billion and mortality
costs were $9.2 billion (National Heart, Lung, and Blood Institute). Functional
replacements would not only eliminate the need for LVRS, but could restore full or
partial functionality to the inflicted tissue.
Engineered tissue replacements must be capable of load bearing during
ventilation and perfusion of oxygen and carbon dioxide between air and blood. This
requires the tissue to have two important components: A functional respiratory
membrane and a functional extra-cellular matrix (ECM).
Recreating the respiratory membrane involved choosing cell types that were
representative of those found within the membrane layers. In addition, cell types
that were used offered contributions toward ECM production and tissue
vascularization.
ECM recreation is the most important factor in reproducing the mechanical
characteristics of native lung tissue (Yuan, et al, 2000). The individual ECM
components are responsible for the majority of load bearing and elastic recoil;
therefore, percentages of these ECM components should correspond to that of
native tissue.
We identified two cell types that should be useful in this study, human fetal
lung fibroblasts and human microvascular endothelial lung cells. Fetal lung
fibroblasts were studied because these cells are found within the interstitial layer of
the respiratory membrane. They also offer numerous population doublings and
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have been shown to secrete proteins needed for ECM production. Human
microvascular lung endothelial cells were also studied because of their role in the
vasculature of native lung tissue. These cells line the lumen of the lung capillaries
and compose the endothelial layer of the respiratory membrane.
Templates are needed to facilitate cell adhesion and tissue organization.
PGA polymer scaffolding has been proven to provide the desired results for
generating different types of 3D tissues. We used these scaffolds to induce cell
proliferation and ECM production under static growth conditions. Following cell
seeding and attachment, dynamic growth conditions were employed to facilitate 3D
growth.
Following the development of these tissue constructs, it was important to
establish the mechanical and morphological characteristics associated with them.
Characterizations included SEM imagery, tensile tests, and biochemical analysis of
the ECM.
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3. SIGNIFICANCE AND BACKGROUND OF THE STUDY
The respiratory system provides a protected interface for diffusion of
nutrients between air and blood. Diffusion occurs within the alveoli, or air-filled
pockets that fill the lungs. These exchange sites are connected to the interstitial
fluids through the cardiovascular system, which transports oxygen to peripheral
tissues and carbon dioxide to the lungs. The total surface area of the alveoli,
estimated to be 35 times greater than the surface area of the body, accommodates
the peripheral tissues nutrient requirements.
The human body consists of a right and left lung. The lungs are made up of
individual lobes separated by deep fissures, the right having three lobes, and the left
having two. The bronchial tree distends into the lung structure and branches
further into each individual lobe and still further to the terminal
bronchioles(Starcher, 2000). Terminal bronchioles give way to pulmonary lobules
that contain the alveoli. Microstructure of the alveoli consists of capillaries
surrounded by a network of elastic fibers. These elastic fibers are responsible for
holding alveolar shape and reducing the lumen size during exhalation. The alveolar
epithelium is composed of squamous epithelial cells or Type I cells and septal cells or
Type II cells which are responsible for surfactant production that reduces the
surface tension within the alveoli (Starcher, 2000). Gas exchange occurs at this level
across the respiratory membrane containing a squamous epithelial cell lining,
endothelial cells lining the lumen of the adjacent capillary, and a fused basement
membrane that lies between the two. The entire respiratory membrane has an
average thickness of 0.5pm.
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There are two structural factors that are fundamentally important to
successful gas-exchange within the lung: the gas exchange surface area and the
thickness of the air-blood barrier in the pulmonary parenchyma. These factors are
dependent upon the dimensions and morphology of the lung capillary network, its
total volume, the density of its meshes, and its 3D structure.
The gas-exchange region of the lung is composed of three main
compartments: air, blood, and tissue (Starcher, 2000). The tissue provides the
framework for the two dynamic and continuously moving compartments of blood
and air. It also keeps the blood and air compartments separate, but allows for
intimate contact to ensure rapid uptake of oxygen and release of carbon dioxide.
The tissue compartment, also known as the septal interstitium, is comprised of two
different phenotypes of myofibroblasts.
Lung morphogenesis depends on the interaction between two tissue layers,
epithelium and mesenchyme. More specifically, the characteristic branching
morphogenesis of the bronchial epithelial buds depends on interaction with
bronchial mesenchyme (Keyzer and Post, 1999). In conjunction with branching,
numerous different cell phenotypes are formed along the anterior-posterior axis of
the epithelial tubules and mesenchyme (Keyzer and Post, 1999). Each of these cell
types exhibits different morphologies and patterns of gene expression (Keyzer and
Post, 1999).
There are numerous growth factors that act as inductive signals mediating
tissue interactions and regulating branching morphogenesis including: Epidermal
7
growth factor (EGF), Transforming. growth factor alpha (TGF-a), Amphiregulin
(AR), Insulin-like growth factors (IGFs), Fibroblast growth factors (FGFs),
Hepatocyte growth factor (HGF), Platelet-derived growth factor (PDGF), and
Transforming growth factor beta (TGF-P).
The EGF, TGF-a, and AR proteins are found in the bronchial epithelium
and expressed locally in the mesenchyme, suggesting that the growth factors are
produced in the mesenchyme and act on the epithelium (Keyzer and Post, 1999).
These growth factors are thought to influence growth and branching
morphogenesis. IGFs may play a role in lung development, but do not appear to be
a major determinant during morphogenesis (Keyzer and Post, 1999). FGFs have
been shown to play key roles in growth and morphogenesis of the developing lung.
Members of this growth factor family are thought to be responsible for mesoderm
patterning, limb pattern formation, and stimulating proliferation; FGFs can be
found in most types of developing lung cells (Keyzer and Post, 1999). HGFs are
produced by fetal lung fibroblasts and stimulate proliferation of adult type II cells.
These growth factors are thought to transduce mesenchymal-epithelial signaling.
However, these cells do not seem to play a role in branching morphogenesis (Keyzer
and Post, 1999). PDGFs are implicated in embryonic development, but further
studies need to be done to determine their specific roles (Keyzer and Post, 1999).
TGF-P exhibits a variety of biological effects including regulation of ECM and
production of integrin expression (Keyzer and Post, 1999).
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Although many growth factors have been characterized in their relation to
lung development, caution must be taken when including these factors to cell
cultures. Exogenous growth factors have been shown to cause inhibitory effects on
branching morphogenesis and proliferation. In addition, other problems may arise
due to unknown effects of one or more growth factors on another. In this study no
additional growth factors were considered outside those used in standard protocols.
The ECM of lung tissue regulates the behavior of cells that interact with it
and ECM content is an important factor in the mechanical properties that a tissue
exhibits (Keyzer and Post, 1999). The ECM can be defined as a structural network
of collagen, elastin, glycoproteins, proteoglycans, fibronectin, and integrins that
surround the different cells of the lung (Starcher, 2000). The ECM also functions as
a dynamic modulator of various biological processes including: development,
migration, proliferation, morphology, and metabolic functions (Keyzer and Post,
1999). This is accomplished through selective binding and subsequent release of
growth factors and cytokines, and through its interaction with cell surface receptors
(Starcher, 2000). Development of the lung requires cellular multiplication,
differentiation, and an integrated system of signals to modulate these processes. The
ECM provides the necessary framework for the expansion of each lung
compartment (Starcher, 2000). The major stress-bearing constituents of lung tissue
are elastin and collagen fibers. These fibers have considerably different individual
properties, but work in conjunction with each other to handle the stresses associated
with normal lung function.
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Collagen fibers are the major constituent of the ECM and account for 60-
70% of the lung connective tissue protein mass and 15-20% of the total tissue mass
(Keyzer and Post, 1999). These fibers can be found in many different types
throughout the lung tissue. Some examples include collagen type I and III, which
are associated with mesenchymal connective tissue and collagen type IV that can be
found in the basement membranes (Keyzer and Post, 1999). Collagen fibers have a
stiffness that is four orders of magnitude higher than the stiffness of elastin fibers.
Because of this, the collagen fibers are primarily responsible for load bearing at
high strains.
Elastin is the other major component of the connective tissue matrix.
Estimates put its content anywhere between 1.3-47% of the total dry-weight of the
human lung and approximately 27-34% of the lung connective tissue (Chrzanowski
et al., 1980). Elastin organization begins during the pseudoglandular stage of fetal
development and its synthesis increases during the canalicular and saccular stage
(Starcher, 2000). Elastin fibers are arranged uniformly throughout the lung tissue,
which is important because the lung requires an elastic symmetry to function
properly (Starcher, 2000). Tropoelastin, a monomeric soluble precursor of
insoluble elastin, is produced primarily by cells of mesenchymal origin (Mariani and
Pierce, 1999). Development of the alveoli is directly related to the elastic fiber
network. Elastic fibers are generally concentrated in areas of high stress, forming a
ring around the alveoli openings and concentrating at the alveoli junctions
(Starcher, 2000). Elastin fibers within the ECM are responsible for the passive
recoil of those compartments that undergo repeated cycles of expansion and
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contraction (Mariani and Pierce, 1999). The alveolar walls, alveolar ducts,
conducting airways, pleura, and vascular tissue are all dependent on elastin to
absorb and store energy during the expansion of the lung and then use the stored
energy to return to the lung to its original volume (Mariani and Pierce, 1999). In
contrast to collagen fibers, elastin fibers can be stretched to >250% of their original
length, and allow for load bearing at low strains. Elastogenesis appears to be an
important factor in the development and maintenance of normal lung structure and
function; interference with elastin formation has shown to result in severely
abnormal alveolar architecture (Mariani and Pierce, 1999).
Glycosaminoglycans (GAGs) are important for the binding of other ECM
components, cell adhesion molecules and growth factors; the theory is that GAGs
may mediate cell adhesion, structural organization, and proliferation during lung
development (Keyzer and Post, 1999). They are composed of unbranched
carbohydrate chains that bind to proteoglycans and are not considered to be stress-
bearing constituents.
Integrins have been identified as the receptors for attachment between ECM
molecules. In fetal rat lung fibroblasts, and number of integrins have been shown to
function as collagen-binding receptors.
Another important element within the matrix appears to be the glycoprotein
microfibrils. These fibrils are 10-12 nm in length and are thought to provide the
scaffold necessary for elastin assembly (Starcher, 2000).
This study focused on elastin and collagen content of the ECM and the
interaction between the two fibers in relation to tissue biomechanics. It has been
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shown that changes in collagen-elastin matrix contribute to changes in the
viscoelastic properties. Therefore, percents of elastin and collagen must be
measured to help explain the results obtained from the mechanical tests.
Tissue construct development begins by seeding cells onto a scaffold or
template. The use of PGA polymer has been shown to offer the desired properties of
the platform needed to produce 3D tissue equivalents. PGA polymer is composed of
small-diameter fibers that can be aligned or randomly entangled to form a strong,
flexible and porous 3D matrix. This matrix also allows for spatially uniform
attachment of cells while minimizing diffusional constraints of nutrient transfer and
gas exchange during cultivation. This is a result of the porous nature of the
material, which creates large surface areas for increased mass transfer of nutrients
and cell attachment. PGA is also biodegradable and biocompatible. Degradation
times can vary but should degrade in parallel with the accumulation of tissue
components. Its biocompatibility permits stimulation of cell proliferation and ECM
creation without inducing an inflammatory response or side effects. Byproducts
from the polymer during degradation are shown to be non-toxic in vivo. This study
considered the use of non-aligned PGA polymer as a suitable template for
engineering human microvascular endothelial lung cells (HMVELC).
Surface modifications of polymer scaffolds have been shown to increase cell-
seeding densities and improve cell attachment to polymer fibers (Gao, Niklason,
Langer, 1998). Hydrolysis of PGA in iM NaOH transforms ester groups on the
surface of PGA polymer fibers to carboxylic acid and hydroxyl groups (Gao,
Niklason, Langer, 1998). This modification promotes individual cell adhesion and
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serum protein adsorption on the scaffolding without significantly sacrificing the
molecular weight or thermal properties of the original polymer (Gao, Niklason,
Langer, 1998). Serum protein adsorption onto the fibers correlated with an increase
in cell seeding density (Gao, Niklason, Langer, 1998). It is important to optimize
attachment of the cells in order to increase proliferation and create uniform tissue
growth.
Because of construct thickness associated with 3-D tissue growth, it is
imperative that inner cells are receiving proper nutrition to keep them viable.
Bioreactors provide the following properties that stimulate internal and external cell
growth. Uniform mixing of the internal microenvironment is accomplished leading
to high rates of mass transfer (Vunjak-Novakovic, et al, 1997). These reactors also
allow for the regulation and maintenance of pH, gas partial pressures (pO2, pCO2),
nutrient levels, and shear stresses at the tissue surfaces (Vunjak-Novakovic, et al,
1997). These high aspect ratio vessels (HARVs) show a marked improvement over
static culturing conditions in proliferation and DNA content. In addition, a more
aerobic cell metabolism was noted which directly related to a less acidic and less
hypoxic environment (Vunjak-Novakovic, et al, 1997). The rotating vessels suspend
the constructs freely within the microenvironment. The average settling velocity is
2-4 cm/s for speeds of 15-28 rpm (Vunjak-Novakovic, et al, 1997). The settling of
the constructs is responsible for the mixing of the nutrients within the bioreactor.
Reynold's numbers within the bioreactor are between 114-207 and average shear
stress is 1.5 dyn/cm 2 (Vunjak-Novakovic, et al, 1997). In this study bioreactors were
13
used to facilitate the 3D growth of the constructs approximately 3 days after initial
seeding.
14
4. METHODOLOGY AND MATERIALS
4.1 Cell Seeding of Polymer Scaffolds:
The first step in creating a functional tissue equivalent lies in the initial
introduction of the cells to the polymer scaffolding. There are many important
factors that must be met for rapid tissue growth to occur. First, there must be a
high yield of cells to maximize utilization. In addition, these cells must show a high
kinetic rate of attachment to the polymer in order to minimize the time in
suspension for shear-sensitive and anchorage dependent cell types. Finally, cells
must be seeded in a spatially uniform distribution within the polymer to provide for
uniform cell proliferation and homogeneous tissue growth. This uniform
distribution is necessary because the cells must interact with each other to create the
framework for a functional tissue.
PGA polymer scaffolds were cut to the desired shapes and sizes. For tensile
tests, scaffolds were cut into dog-bone shapes measuring 11mm X 5mm X 2mm.
Scaffolds for SEM and biochemical analysis were cut into discs measuring 5mm in
diameter. Each scaffold was modified by the hydrolysis protocol (Appendix A).
Seeding density was established to be 3-4 x 106 cells/scaffold. Cells were
trypsinized and removed from the culture flasks. After centrifuging (125 x g for 5
min, the cells were resuspended in 1 ml of the appropriate warmed growth media.
Modified scaffolds were placed into a 20m1 syringe. The cell suspension was
drawn up and subsequently dispensed to force cells through the scaffold matrix.
This was repeated 3 times for each scaffold. Each scaffold was then removed and
placed into 1 ml of the cell suspension in a 50 ml centrifuge tube for 2 hours in an
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incubator (37*C and 5% CO 2) to allow for cell attachment. The cap on the
centrifuge tube was vented to allow for gas exchange. After 2 hours, the scaffolds
were transferred to 25cm3 flasks containing 15 ml of growth media (37*C and 5%
CO 2). Constructs remained in this static environment for 2 days. Media (100%)
was changed daily to ensure optimal cell nutrition. After 2 days, the constructs were
transferred to a dynamic environment within the bioreactor.
Dynamic culturing has been shown to greatly increase the cell distribution,
proliferation within the polymer matrix, and metabolic activity of the cells (Vunjak-
Novakovic, et al, 1997). Although a dynamic environment appears to be beneficial,
at high speeds can prove to be detrimental when turbulence can cause accelerated
mechanical degradation, polymer fragmentation, and shear stress forces that
adversely affect the cells. Therefore, it was appropriate to monitor each specific
case and determine the optimal dynamic parameters. The bioreactor was set at the
highest possible speed where the construct did not contact the vessel walls or
become turbulent in nature. For most cases this was between 11-17rpm. This
ensured that the highest possible shear forces would be acting on the construct,
promoting increased mass transfer and secretion of proteins required for ECM
production. Constructs were cultured in this dynamic environment for up to 10
days. Constructs were sampled at different time periods to be tested for mechanical
and morphological properties. Constructs that were sampled were fixed in
Hexamethyl Disilizane (Appendix A). Characterizations were done within 24 hours
to obtain the best possible results and limit any effect the fixative may have to the
tissue properties.
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4.2 Tensile Test Protocol
Mechanical testing was done using the Bose® ELectroForce ELFTM 3200.
Samples were measured for length, width, and thickness prior to testing. For blank
samples the initial length was set to 6.35mm and for IMR-90 samples the initial
length was 9.00mm. The initial lengths were determined by the size of the samples
to be tested. Every sample tested was stretched a maximum of 12mm. This
stretching was done at a rate of 5mm/minute. Values for stress and strain were
calculated from the results and graphing stress vs. strain will allow for calculations
of the Elastic Modulus for each sample. Averages for samples subjected to the same
culture conditions were also calculated. Yield stresses were also calculated for each
sample and averaged for each sample group.
Tensile measurements were made using the Bose ELectro Force 3200, which
was connected to a PC for data collection. Stress T and strain E values can be found
from equation 1.
E)= T(t)= (1)
where 1 is length, lo is initial length of strip, F is force, t is time, and AO is initial
cross-sectional area determined by measurements using a Bemier caliper.
Although these samples may not be comparable to native lung tissue at this
time, it does offer insight into cell morphology and ECM recreation within the tissue
samples.
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4.3 SEM
Scanning electron microscopy (SEM) was performed on individual tissue
strips to determine morphological properties. Pictures were taken of blank polymer
scaffolds as well as those seeded with cells. This offered a comparison in order to
distinguish biological components from non-biological components. In addition,
polymer degradation can be characterized in accordance with culture time and
conditions. Analyzing tissue samples allowed for detection of cell attachment,
ingrowth, and organization. ECM set-up and organization was also noted.
4.4 Biochemical Analysis
Endothelial and Fibroblast constructs were sampled after 7 days, and the
total wet weight of the samples was acquired. The samples were divided into four
equal parts to be used in the biochemical assays. The four parts were used to obtain
a-elastin, salt-soluble collagen, acid-soluble collagen, and pepsin-soluble collagen
(Appendix A). These four extracts were then quantified using a dye-binding method
(Appendix A). Data was compared against a standard curve to give values for total
elastin and collagen content.
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4.5 MATERIALS
4.5.1 Human Microvascular Endothelial Lung Cells (HMVELC)
HMVELC were obtained (Clonetics, Walkerville, MD) in an ampule
containing 572,500 cells. The cells were acquired from a female donor, age 45. Cell
viability was 77% and had a seeding efficiency of 25%. HMVELC were of passage
4 and had a 34-hour doubling time for a guaranteed 15 population doublings.
4.5.2 EGM-2 MV Growth Media for HMVELC
Endothelial Cell Basal Medium-2 (EGM-2 MV) was obtained (Clonetics,
Walkerville, MD) and combined with the following growth supplements: Human
endothelial growth factor, Gentamicin sulfate amphotericin-B, Fetal bovine serum,
Vascular endothelial growth factor, Human fibroblast growth factor, Long R
Insulin-like growth factor-1, and Ascorbic acid.
4.5.3 Human Fetal Lung Fibroblasts (IMR-90)
IMR-90 cells were obtained (American Type Culture Collection (ATCC),
Manassas, Virginia) in a lml ampule containing 1.6 million cells with a viability of
1.5 million cells. These cells were acquired from the lungs of a 16-week female fetus.
Expected viability of these cells is 91%-97%. These cells are of passage 10 and 24.2
population doublings. The cells are reported to be capable of obtaining 58
population doublings before the onset of senescence.
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4.5.4 EMEM Supplemented Growth Media for IMR-90 Cells
Eagle's Minimal Essential medium with Earle's BSS and 2mM L-glutamine
(EMEM) was obtained (Fisher Scientific, Atlanta, GA) and modified to contain:
1.0mM sodium pyruvate, 0.1mM nonessential amino acids (NEAA), 1.5g/L sodium
bicarbonate, and 10% fetal bovine serum (FBS).
4.5.5 Bioreactors
A rotary cell culture system (RCCS) was obtained from Synthecon Inc.,
Houston TX. The system incorporates a 4-station rotator base capable of rotating at
4 independent speeds. Each rotator base held a single 50 ml disposable culture
vessel, also known as a high aspect ratio vessel (HARV).
4.5.6 PGA Polymer Scaffolding
PGA polymer scaffolds were obtained (Synthecon Inc.) in 10 cm x 10 cm
squares. The nature of the polymer is unaligned and has a thickness of 2mm.
Individual scaffolds were cut from these pieces in the same direction.
4.5.7 Analytical Assays
Elastin and Collagen content of tissue samples were done using commercially
available assay kits obtained from Accurate Chemical and Scientific Corp.,
Westbury, NY. Samples were divided into equal parts and quantified for elastin,
salt soluble collagen, acid soluble collagen, and pepsin soluble collagen. Results
obtained were compared against a standard curve for known samples to determine
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quantitative values. These results were then averaged to determine average elastin
and collagen content. In addition, ratio of elastin to collagen was also determined.
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5. RESULTS
Blank polymer control samples were analyzed using tensile tests and SEM
photos. Tensile tests were done on samples at varying time periods. These included
tests on original untreated polymer, hydrolyzed polymer, and polymer that had
been hydrolyzed and soaked in growth media for 24 hours. Further tensile tests
were conducted on samples cultured for 2, 3, 4, 5, and 7 days.
SEM photos of the controls show the degradation of the polymer with
relation to time in culture (Fig 1.1-1.3). Photos were taken from samples that had
been hydrolyzed and soaked in media for 24 hours and then cultured for 3 or 7
days.
Fig 1.1 SEM photo of 3-day old blank polymer. Polymer fiber has been cleaved at one end and further
degradation is noted by striations along fiber.
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Fig 1.2 Degradation of individual polymer fiber from 7-day old blank sample.
Fig 1.3 Degradation of polymer mesh network from 7-day old sample.
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Degradation of the PGA polymer fibers is noted by striations in the
individual strands. As time proceeds, degradation continues along the fissures of
the striated regions until the polymer is cleaved off at this site. Degradation of
polymer also occurs as a loss in diameter over time. Original polymer fibers have
diameters varying from 15-25 um. Loss of diameter can vary based on location of
polymer strand, cell attachment, and culture conditions.
Blank samples tested under static conditions maintained their structural
integrity for longer than 21 days. Blank samples cultured in static for 2 days then
dynamically for 5 to 8 days maintained their structural integrity up to day 6
(Fig2.1).
Elastic Modulus Comparison
*
0.5 -
0.45 _ -
0.4 ---- -
0.35 --___ __ _0.35 - Elastic
Modulus
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0.2
0.15
0.1
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0
a
Sample Group
Fig 2.1 Elastic Modulus comparison of statically cultured (S) and dynamically cultured (D) blank polymer
blank polymer scaffolds. Statistical analysis was done using Welch's t-test, and significant differences
were found between these two groups (*).
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We found that original, hydrolyzed, and hydrolyzed-soaked polymer
scaffolds, that were subjected to static culture conditions (S), showed a significantly
higher (p<0.005) (Appendix C) elastic modulus than hydrolyzed-soaked polymer
scaffolds that had been cultured dynamically (D) for >2days (*).
Yield Stress Comparison
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Fig 2.2 Yield Stress comparison of statically cultured (S) and dynamically cultured (D) blank polymer
blank polymer scaffolds. Statistical analysis was done using Welch's t-test, and significant differences
were found between these two groups (*).
When we plotted yield stress for the same sample groups we found a similar pattern.
Statistically, polymer in static culture had a significantly higher (p<0.005)
(Appendix C) yield stress compared to polymer cultured dynamically (*).
Early experiments included seeding HMVELC onto PGA polymer fibers.
Initial problems arose with cell attachment of the endothelial cells to the polymer.
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This was overcome by subjecting the polymer scaffolding to hydrolysis prior to
seeding. Improved cell attachment was noted on samples photographed after 3
hours of seeding (Fig 3.1). This photo shows how cells have attached to the PGA
polymer fiber and have begun to aggregate between strands.
Fig 3.1 SEM photograph at a magnification of 550X shows endothelial cell growth between polymer fibers.
This picture was taken 3 hours post-seeding.
Additional tissue constructs were seeded with HMELC and cultured for
periods up to 12 days. Under phase contrast microscopy, cell attachment and some
ingrowth between polymer fibers was noticed. SEM photos were taken of the
samples to further indicate these characteristics. The most common morphology
noticed was a monolayer of endothelial cells covering individual polymer fibers (Fig
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3.2). Here the endothelial cells can be seen lying down on the polymer fibers (Fig
3.3).
Fig 3.2 and Fig 3.3 Endothelial cell attachment and growth along polymer fiber. These pictures were
taken from 3-day old samples cultured under static conditions.
27
Under static conditions the endothelial cells did show some ability to attach
between fibers. Cell growth in the above samples was strictly seen as monolayers
attaching to the polymer fibers.
Samples that were cultured for 3 days or longer showed endothelial cell
attachment across cleavage sites created by polymer degradation (Fig 3.4-3.6).
Fig 3.4 3-day old sample showing endothelial cell growth between polymer fibers.
Fig 3.5 7-day old sample showing endothelial cell growth between polymer fibers. Polymer strands havc
degraded to a diameter of approximately 3-5um.
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Bensilemia asays werdno e done on aendothelial constructs tat ady bie
cultured for 7-days. Neither elastin nor collagen was present in any of the construct
samples that were tested. Fig 4.1 and Fig 4.2 are the collagen and elastin standards
that were generated for the biochemical tests on the endothelial constructs. Values
from collagen and elastin samples were obtained and amounts were calculated using
these standard curves. In this case all values obtained were at or below values of
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blank samples. Therefore it was concluded that no elastin or collagen was present
in any endothelial contructs.
Collagen Standard
y = 0.0081x
R2 = 0.9979
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0.5 - ---
0.4
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0
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ul of collagen
Fig 4.1 Collagen standard curve for endothelial constructs.
Elastin Standard
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Fig 4.2 Elastin standard curve for endothelial constructs.
SEM photos of fibroblast cell constructs cultured under static conditions for
3 days show cell attachment to PGA polymer fibers (Fig.5.1). Also noted is
30
connective elements that are visible between the cell mass and the fiber strands
(Fig.5.2). These elements are most likely collagen fibers.
Fig 5.1 Fibroblast cell attachment to polymer fibers under static conditions.
Fig 5.2 Fibroblast cells and extra-cellular matrix components.
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Fig 5.3 Fibroblast cell attachment to polymer fibers and cell ingrowth. Connective elements of the ECM
can also be seen in cell-cell and cell-polymer interactions.
The fibroblasts showed an increased amount of cell proliferation and cell
ingrowth when moved to dynamic culture conditions. The morphology of the
fibroblasts indicates an elongated shape. SEM picture is of a 10 day-old lung tissue-
polymer construct (Fig.5.3). Magnification at 700X shows fibroblast growth around
polymer fibers. The polymer fiber in this picture is approximately 10um in
diameter, which corresponds to expected sizes of degraded polymer strands.
Fibroblast cells in this picture have aligned in the same direction as dynamic flow
and connective elements are seen extending between cells and the polymer fiber.
Increased magnification of 7-day old samples indicates the formation of a
structural matrix within the polymer network (Fig. 5.4). Magnification at 10,000X
shows this matrix in more detail (Fig. 5.5.).
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Tensile tests results from 7-day samples of IMR-90 fibroblast constructs
demonstrate an average Elastic modulus of 390077 482294 Pa. Individual sample
moduli were 946352 Pa, 134880Pa, and 88999 Pa (Fig 6.1). All 3 samples showed an
Elastic modulus greater than the average modulus for 2-to-5-day blank polymer
groups.
IMR-90 Elastic Moduli
0.8-
0.6
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0.4 - - -__ _
0.2
0
1 2 3
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Fig 6.1 Comparison of IMR-90 (fibroblast) construct Elastic moduli.
IMR-90 Yield Stress
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Fig 6.2 Commparison of IMR-90 (fibroblast) construct yield stresses
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Fig 6.3 Yield strain for individual IMR-90 (fibroblast) samples
Yield stress (Fig 6.2) and yield strain (Fig 6.3) comparisons were also done.
In sample number one we noticed a yield stress that was approximately twice as
much as in samples two or three. However, the corresponding yield strain was 31
percent lower than sample 2 and 55 percent lower than sample 3.
We then averaged these results for elastic modulus, yield stress, and yield
strain and compared them statistically to unseeded polymer samples under multiple
culture conditions (Fig 6.4-6.6).
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Fig 6.4 Elastic modulus comparison of blank-static (S), blank-dynamic (D), and IMR-90 (fibroblast)
construct. Statistical comparison was done using Welch's t-test (Appendix C), suitable for small sample
groups.
Yield Stress Comparison
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Fig 6.5 Yield Stress comparison of blank-static (S), blank-dynamic (D), and IMR-90 (fibroblast)
constructs. Statistical comparison was done using Welch's t-test (Appendix C), suitable for small sample
groups.
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Fig 6.6 Yield stress comparison of blank-static (S), blank-dynamic (D), and IMR-90 constructs. Statistical
comparison was done using Welch's t-test (Appendix C), suitable for small sample groups.
We cannot say statistically that the elastic modulus or the yield stress of the
fibroblast constructs were significantly different from the dynamically cultured
blank polymer samples (D). This is partially due, in both cases, to the high variance
that is seen between the elastic moduli and yield stresses of the three individual
fibroblast samples. However, we did note a significant decrease in yield strain from
both the static and dynamic blank samples. This indicates that the IMR-90 samples
are much more fragile than the blank polymer.
Biochemical analysis quantitatively proved the existence of both elastin and
collagen within the IMR-90 constructs. Results from the assays were compared
against standard curves of known elastin (Fig 7.1) and collagen (Fig 7.2) samples to
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determine actual values of elastin and collagen in the tissue samples. These values
were reported as a percentage (%) of total wet weight for the IMR-90 samples.
Elastin Standard Curve
y = 0.0005x
R2 = 0.9593
0.045 . -
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Fig 7.1 Elastin Standard curve for soluble elastin from IMR-90 constructs.
Collagen Standard Curve
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Fig 7.2 Collagen Standar curve for collagen content of IMR-90 constructs.
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IMR-90 constructs were evaluated and duplicate samples were assayed.
Group one contained an average of 94.2pg of elastin/50ul of elastin extraction. This
group had a total of 110 l of extraction. The total elastin content for group one was
207.24pg, which was approximately 2.59% of the total wet weight. Sample group
two contained an average of 81.1 g of elastin/50pl of elastin extraction. This group
had a total of 140p1 of extraction. The total elastin content in group two was
719.08 g, which was approximately 3.78% of the total wet weight. The standard
error for these groups was 4.07%. Therefore, the average elastin content of the two
sample groups was 3.19% of the total wet weight.
The IMR-90 groups were also tested for collagen. Duplicate samples were
assayed to determine contents for salt soluble, acid soluble, and pepsin soluble
collagens. These parts were then added to determine total collagen content of the
samples. Sample group one contained an average of 26.99 g of salt soluble
collagen/100p, 30.30pg of acid soluble collagen/1001, and 33.35 g of pepsin soluble
collagen/100pl. Total extract volumes for the group was 980l, 920pi, and 930pl
respectively. Amounts were extrapolated and determined to be 1428.30 g total salt
soluble collagen, 1505.52pg total acid soluble collagen, and 930.60pg total pepsin
soluble collagen. Total collagen content of group one was calculated to be
3864.42pg, which was 14.31% of the wet weight. Group two contained an average of
24.81pg of salt soluble collagen/100gl, 35.79pg of acid soluble collagen/100pl, and
21.44 g of pepsin soluble collagen/100p. Total extract volumes for the group was
980 1, 950p, and 960pl respectively. Amounts were extrapolated and determined to
be 770.08pg total salt soluble collagen, 1615.24g total acid soluble collagen, and
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.44pg total pepsin soluble collagen. Total collagen content of group two was
calculated to be 3 167.72 g, which was 16.67% of the wet weight.
The average collagen content for the two sample groups was 15.49% of the
total wet weight.
Group one ECM content
1600 1505.52
1400
1200 --
1000 9306
800 699.44
600
400
200
0
Elastin Collagen Collagen Collagen
Salt soluble Acid soluble Pepsin soluble
Fig 7.3 Total amounts (ug) of elastin and collagen in group one.
Group two ECM content
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Fig 7.4 Total amounts (ug) of elastin and collagen in group two.
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Fig 7.5 Average values of total elastin and collagen content in batch 1 and 2.
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6. DISCUSSION
Mechanical and morphological analysis was done to characterize our
engineered tissue constructs. We used SEM imagery to provide us with a
description of the organization of cellular components within the tissue constructs.
With this type of analysis we can observe how cell attachment occurs and what type
of organization the cells undergo. In addition, these images provide insight on
formation of ECM components. We used biochemical assays to quantitatively
measure ECM components, specifically elastin and collagen. After quantification of
ECM components, we measured mechanical properties of the samples in order to
differentiate between the contributions of the tissue and polymer components. It
also becomes necessary to understand cell and ECM contribution to the mechanical
properties of the engineered constructs and how we can optimize these constructs to
support the loads required for lung function.
We analyzed both endothelial and fibroblast constructs, but only fibroblast
constructs provided results in all three characterizations. SEM images of these
constructs at different time periods showed cellular outgrowth, forming a network
of cells across individual fiber strands. In addition, we observed evidence of ECM
expansion (elastin or collagen fibers) stretching between cells and polymer fibers.
This was concluded based on the relative size of the strands. These strands are very
small (in diameter) relative to polymer fiber diameters. We also compared the sizes
of these strands to images taken of blank polymer constructs at comparable
magnifications and time in culture. We surmised that these strands are a part of the
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fibroblast cell due to the regularity of shape and relatively large length. Fibroblast
cells that are seen in static culture flasks have very irregular shapes.
By extracting the solubilized elastin and collagen from the fibroblast
constructs, we were able to verify the presence of ECM components, which
strengthens our conclusions based on the SEM images. Quantitative results show
that the average elastin content for the engineered constructs cultured for 10 days
was 3.19 0.8% of total wet weight of the original samples. Average collagen
content was 15.49 1.67% of total wet weight for the same samples. We cannot
compare these percentages to those obtained from native tissue because the total
weight of our constructs also includes polymer that has not yet degraded. However,
we are able to compare the elastin-collagen ratio that we obtained with the elastin-
collagen ratio from the ECM of native tissues. In our constructs there was an
approximate ratio of 1:5, meaning there was five times the amount of collagen
present. Native tissue ratios are on the order of 1:2. We hypothesize that there is a
lack of elastin instead of too much collagen production. This is most likely due to
the relative age of the fetal lung fibroblasts. The IMR-90 cells that we used are 16
weeks in age, and elastin production in fetal lungs has been shown to peak during
the later stages of fetal development. What is of importance though is that we were
able to produce both component fibers within a relatively short period of time.
With extended culture periods we expect to see a ratio closer to that of native ECM.
Knowing that some semblance of an ECM has been created and that this will
directly affect tissue mechanical properties, we subjected these samples to tensile
tests and compared to previously tested blank polymer scaffolds. Initially, tensile
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tests were done on blank scaffolds at different time periods to determine the effects
of modification and degradation on the mechanical properties. Because there are a
limited number of samplings per time period, more samples will need to be tested to
get more accurate results. However, we can describe the general trends associated
with polymer modification and degradation. In the test, we calculated yield stress,
elastic modulus, and yield strain for each of the samples. Statistically, we noticed a
significant difference between blank polymer scaffolds that were cultured under
static conditions and blank polymer scaffolds that were cultured dynamically. Both
elastic modulus and yield stress were higher in the statically cultured samples.
However, we could not statistically determine any significant difference in yield
strain between static and dynamic blank polymers. This shows that all of the
polymer samples could be stretched to relatively the same length. These tests
indicate that dynamic conditions greatly increase polymer degradation resulting in a
loss of some mechanical properties. Surface degradation of polymer fiber strands
was also noticed when examining SEM images. Original diameter sizes were
approximately 15-25pm compared with 7-10 m diameters that were seen in
dynamically cultured samples. In addition, striations along the polymer fibers
confirm bulk degradation of the polymer.
We can see that the average elastic modulus and yield stress from the IMR-
90 samples is higher than that of the dynamically cultured blank polymers.
However, it should be noted that we couldn't statistically determine if these values
are significantly different due to the high variance associated with the three
individual IMR-90 samples. We are most interested in this comparison because the
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properties of the polymer under dynamic conditions should closely relate to the
polymer properties in the IMR-90 constructs. Therefore, any differences between
the samples should be attributed to any cellular components that may be present.
There was a significant decrease in the yield strain of the IMR-90 constructs and
both static and dynamic blank samples. This indicates that the IMR-90 samples
were much more fragile. Although the tissue components may add strength they did
not contribute to elongation. This finding coincides with the elastin and collagen
content that was noted. With such a high ratio of collagen to elastin, it is expected
that the tissue constructs would not show a high elasticity.
When we compare the individual IMR-90 samples to the blank polymer
averages we can see that sample 1 has a much higher elastic modulus and yield
stress than the blank samples. With samples 2 and 3 these values are only slightly
higher. This variance is most likely due to non-uniform surface modification during
hydrolysis. This phenomena creates regions on the scaffolding where cells may not
be likely to attach in large numbers ultimately lowering cell seeding density. If this
is the case then we will get constructs that have lower tissue masses and non-
uniform growth. Mechanical properties that we see may not be much different than
that of samples 2 and 3. However, if we achieve uniform hydrolysis and high
seeding density then we may see mechanical properties like sample 1. If we can
duplicate the mechanical properties seen with this case, we may be able to provide
the properties needed for load bearing under physiological conditions.
SEM photos were also taken of endothelial cell constructs and studied for cell
attachment and organization. Attachment of the cells to the polymer fibers was
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noted, however, these cells did not show the branching that was seen with the
fibroblasts. Endothelial cells are characteristically monolayer type cells, and this
may account for the limited ingrowth on the scaffolds. However, these cells were
able to proliferate and grow under dynamic culture conditions suggesting that this
cell type may still be suitable for use within co-culture constructs. Quantitative
values from tests for elastin and collagen were negative. This may be the result of
the relative age of the cells. Since these are adult cells and not fetal cells, they may
not be active in producing the needed ECM proteins. We attempted mechanical
tests on 7-day old endothelial constructs, but these cells lacked the structural
integrity necessary to comply. This corresponds to the results that we saw from the
elastin and collagen tests.
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7. CONCLUSION
We have grown fibroblast (IMR-90) and endothelial lung tissue constructs
using PGA polymer scaffolds as templates. These constructs were cultured
dynamically and characterized to determine their morphological and mechanical
properties. Each of these constructs has offered results that can be used to
determine future directions related to this study.
During these experiments we were able to facilitate fibroblast and endothelial
cell attachment to polymer strands through hydrolysis of the polymer. This
successfully led to the growth of tissue constructs that could then be characterized.
Fibroblast construct characterization proved to be most noteworthy.
Excellent cellular organization and ingrowth were seen in SEM images and ECM
components, elastin and collagen, were quantified by biochemical analysis. In,
addition, some of these tissue constructs showed increased elastic modulus and yield
stress in relation to blank polymer samples that had also been cultured dynamically.
These results prove that fibroblast lung cells will provide, in part, the necessary
cellular components for load bearing at physiological strains.
In contrast, endothelial constructs did not provide the mechanical properties
that were seen in the fibroblast constructs. These cells failed to yield any ECM
components and lacked the structural integrity necessary for tensile testing.
However, we do know that these cells are an essential component of the respiratory
membrane, and will need to be studied further to determine their role in membrane
recreation.
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With this project we were able to do some initial characterizations that will
guide future work. However, it should be noted that these characterizations were
done on a very limited number of samples due to time constraints of growing
individual samples and the cost associated with it. More samples should be tested to
gather more accurate results.
Future directions related to this study will have to include the co-culture of
multiple cell types to determine their interaction and organization with respect to
each other. Further experiments may also explain the affects of the dynamic culture
environment on cell proliferation versus ECM formation. As the respiratory
membrane begins to come together, tests must also be done to quantify the
functionality in relation to the exchange of oxygen and carbon dioxide.
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APPENDIX A
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Protocols:
PGA Polymer Preparation Protocol
Scaffold samples were cut from an original piece of a 10cm x 10cm PGA
polymer square. Dogbone scaffolds measured ~10mm in length and all were cut in
the same orientation in relation to the original polymer square. Disc scaffolds were
cut to measure ~ 5mm in diameter.
Hydrolysis Protocol
Scaffolds were modified by hydrolysis using a 1M NaOH solution (Gao,
Niklason, Langer, 1998). First, scaffolds were washed in hexane to remove any
contaminants from the fibers. Scaffolds were then filtered using multiple Kimwipes.
Once dry, they were soaked in 100% Ethyl Alcohol, placed into a 15m1 centrifuge
tube containing 10ml of distilled water, and shaken for 5 minutes to allow for
solvent exchange. Scaffolds were immediately moved to a 15ml centrifuge tube
containing 10ml of the NaOH solution and shaken for 1 minute, 15 seconds.
Scaffolds were then removed from the tubes and placed into 5 consecutive beakers
of filtered water (5 minutes each) to ensure that a neutral pH is reached. The
scaffolds were again soaked in 100% Ethyl Alcohol and transferred to a biohood
where they were filtered using multiple Kimwipes. Transferring the scaffolds to a
biohood reduced the chance that contamination would occur. Scaffolds were then
placed into the appropriate media, depending on cell type, overnight in an incubator
to allow for serum absorption into the fibers. This process also allowed the scaffold
to equilibrate to 37*C and 5% CO 2.
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HMVELC Protocols
Subculturing Protocol
(Stated volumes are for 75cm3 flask)
We removed and discarded the culture medium. We then rinsed the cell layer
with Delbecco's Phosphate-Buffered Saline (PBS) to remove traces of serum that contain
trypsin inhibitor. We added 6ml of 0.025% (w/v) Trypsin-0.01% EDTA that had been
warmed to 37*C. We observed the cells under an inverted microscope and tapped bottom
of flask to encourage cell detachment. When all cells looked to be rounded and contained
within the trypsin solution, we added 12ml of PBS to neutralize the trypsin. We removed
the cell suspension and centrifuged (125 x g for 5 minutes) to concentrate the cells. We
then aspirated the growth media by gently pipeting off the supematant. We resuspended
the cells into the appropriate amount of EGM-2 MV growth media (37 C) and aliquoted
into new 75cm 3 flasks. Subcultivation ratio was 1:2 to 1:8.
Media Renewal Protocol
Media was changed 100% every 2 days according to following schedule:
1.0ml/5cm 3 at 0%-30% confluence, 1.5ml/5cm 3 at 30%-60% confluence, and 2.0ml/5cm 3
at 60%-90% confluence.
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Initial Cell Culture and Cryopreservation
Human microvascular endothelial lung cells were obtained in 1 ml ampules.
Frozen cells were removed and thawed by placing into a water bath at 37 C. Vials were
gently swirled until just thawed. Cells were then divided into 3-25cm 3 culture flasks
containing 10ml of EGM-2 MV supplemented growth media that was equilibrated at
37*C and 5% CO 2. At 90% confluence cells were subcultured into 2-75cm 3 flasks
containing 15ml of EGM-2 MV growth media. Flasks were then subcultured, centrifuged
(125 x g for 5 minutes), and resuspended in a prepared solution of 95% EGM-2 MV
growth media/5% DMSO at a concentration of -20,000cells/ml. Aliquots of lml were
placed into 1.5ml cryovials and placed into a -80 C for 24 hours then immediately
transferred into liquid nitrogen storage. Vials were labeled with date, cell type, and
passage number. These cells were of passage 5.
IMR-90 Protocols
Subculturing Protocol
(Stated volumes are for 75cm 3 flask)
We removed and discarded the culture medium, then rinsed the cell layer with
Delbecco's Phosphate-Buffered Saline (PBS) to remove traces of serum that contain
trypsin inhibitor. We then added 6ml of 0.25% (w/v) Trypsin-0.03% EDTA that had
been warmed to 37*C. We observed the cells under an inverted microscope and waited
for cells to round up and detach (usually within 5 minutes). When all cells looked to be
rounded and contained within the trypsin solution, we added 12m1 of PBS to neutralize
the trypsin. We then removed the cell suspension and centrifuged (125 x g for 5 minutes)
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to concentrate the cells. We then aspirated the growth media by gently pipeting the
supernatant. We resuspended the cells into appropriate amount of EMEM supplemented
growth media (37*C) and aliquoted into new 75cm 3 flasks. Subcultivation ratio was 1:2
to 1:8. EMEM supplemented media was renewed 100%, every 2-3 days.
Initial Cell Culture and Cryopreservation
IMR-90 cells were obtained in 1 ml ampules. Frozen cells were removed and
thawed by placing into a water bath at 37*C. Vials were gently swirled until just thawed.
Cells were then divided into 3-25cm 3 culture flasks containing 10ml of EGM-2 MV
supplemented growth media that was equilibrated at 37*C and 5% CO 2  At 90%
confluence cells were subcultured into 2-75cm 3 flasks containing 15ml of EMEM
supplemented growth media. Flasks were then subcultured, centrifuged (125 x g for 5
minutes), and resuspended in a prepared solution of 95% EMEM supplemented growth
media/5% DMSO at a concentration of -800,000cells/ml. Aliquots of lml were placed
into 1.5ml cryovials and placed into a -80*C freezer for 24 hours and then immediately
transferred into liquid nitrogen storage. Vials were then labeled with date, cell type, and
passage number. These cells were of passage 11.
Cell Seeding Protocol
Seeding density was established to be 3-4 x 106 cells/scaffold. Cells were
trypsinized and removed from the culture flasks. After centrifuging (125 x g for 5 min),
the cells were resuspended in 1 ml of the appropriate warmed growth media. Hydrolyzed
and presoaked scaffolds were placed into a 20ml syringe. The cell suspension was drawn
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up and subsequently dispensed to force cells through the scaffold matrix. This was
repeated 3 times for each scaffold. Each scaffold was then removed and placed into 1 ml
of the cell suspension in a 50 ml centrifuge tube for 2 hours in an incubator to allow for
cell attachment. We made sure the cap on the centrifuge tube is vented to allow for gas
exchange. After 2 hours the scaffolds were transferred to 25cm3 flasks containing 15 ml
of growth media (37*C and 5% CO 2). Constructs remained in this static environment for
2 days. Media was changed daily to ensure optimal cell nutrition. After 2 days the
constructs were transferred to a dynamic environment within the bioreactor.
Bioreactor Parameters
The bioreactor was set at the highest possible speed where the construct did not
contact the vessel walls or become turbulent in nature. For most cases this was between
11-17rpm. This ensured that the highest possible shear forces would be acting on the
construct, promoting increased mass transfer and secretion of proteins required for ECM
production. Constructs were cultured in this dynamic environment for up to two weeks.
Adjustments to bioreactor speed were done when necessary. Samples were taken at
different time periods to be tested for mechanical and morphological properties.
Bioreactor Media Renewal Protocol
It was necessary to change the media within the disposable vessels on the
bioreactor every 2-3 days. Renewal was done by adding and removing media via the
syringe ports on the disposable vessel. A 20ml syringe and needle was used to execute
renewal.
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Fixation Protocol
Samples that were taken from the bioreactors were fixed before they were tested.
Samples were first dehydrated through a dilution series of EtOH (50/70/90/100%) for 10
minutes each and then placed in Hexamethyldisilizane twice for 5 minutes and airdryed
overnight.
Tensile Test Protocol
Mechanical testing was done using the Bose® ELectroForce ELFTM 3200. Tissue
strips were placed in the machine and stretched at a rate of 5mm/minute. Values for
stress and strain were calculated from the results of these tests. Samples were measured
for length, width, and thickness prior to testing.
Elastin Extraction Protocol
The Fastin Elastin assay kit was used to measure in-soluble elastin. Tissue-
polymer constructs were solubilized in hot oxalic acid for two-1 hour intervals at 95 C.
The samples were then placed on a orbital shaker and precipitated overnight in a 5oC
refrigerator with Fastin precipitating reagent. The samples were then centrifuged using a
microcentrifuge tube fitted with a filter membrane that has a molecular weight cut-off of
~10,000 MW. The oxalic acid free extract contained the tissue elastin in the form of a-
elastin which had an average molecular weight of ~8000 MW. Extracts were saved for
elastin analysis.
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Elastin Assay Protocol
Test samples of 50ul were then aliquoted into 1.5m1 microcentrifuge tubes,
brought up to 100ul by the addition of 0.05M acetic acid solution, and centrifuged (8000
x g for 10 minutes) to pack the precipitated elastin. Following centrifugation, the acid
solution was drained. The microcentrifuge tubes were carefully inverted and gentle
tapping onto an absorbent paper towel ensured removal of all liquid contents. The tubes
now contained only the precipitated elastin. Fastin dye reagent was added to each tube
in lml quantities followed by addition of 100ul of 90% saturated ammonium sulphate. A
vortex mixer was used to bring the elastin precipitate into solution with the dye reagent.
Two short periods were used instead of one long period. The elastin and dye reagents
were then allowed to interact for 60 minutes on orbital shaker at room temperature. The
elastin-dye complex was then collected through centrifugation (8000 x g for 10 minutes).
The supernatants were again discarded in the same manner as stated above. The dye
bound to the elastin pellet was solubilized with the destain reagent and brought into
solution using two short periods on a vortex mixer. Aliquots of 100ul were plated onto a
96-well plate and the absorbance was measured at a wavelength of 530 nm using a
microplate reader (TECAN, NC). A calibration standard containing a-elastin was used to
obtain the standard curve for this experiment.
Collagen Extraction Protocol
Sircol Collagen assay kit was used to measure the total soluble collagen within
the tissue samples. Three different samples were used to quantify the salt-soluble, acid-
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soluble, and pepsin-soluble collagens. Combination of these results yielded the total
soluble collagen content.
Salt-Soluble Extraction Protocol
Salt-soluble collagen was extracted by placing a tissue sample in 1 ml of 1M
NaCl, 0.05M TRIS buffer solution containing protease inhibitors (20mM EDTA, 1mM
PMSF, 2.0mM NEM, lug/ml of pepstatin). Tissue and buffer solution was incubated
overnight on a mechanical shaker at 5*C. Samples were then centrifuged (2000 x g for 10
minutes) to remove particulate matter and the solution was collected for latter analysis.
Acid-Soluble Extraction Protocol
Acid-soluble collagen was extracted by placing a tissue sample in iml of 0.5M
acetic acid solution. Samples were incubated overnight on an orbital shaker at 5 C.
Solution was centrifuged (2000 x g for 10 minutes) and the clear solution was collected
for latter analysis.
Pepsin-Soluble Extraction Protocol
Pepsin-soluble collagen was extracted by placing a tissue sample in lml of 0.05M
acetic acid solution containing pepsin (lmg/10mg tissue sample; Sigma, St. Louis, MO).
Samples were incubated overnight on an orbital shaker at 5"C. Solution was centrifuged
(2000 x g for 10 minutes) and the clear solution was collected for latter analysis.
60
Collagen Assay Protocol
Two test samples of 100ul were taken from each extraction solution and placed
into a 1.5ml microcentrifuge tube. One ml of Sircol dye reagent was added to each tube
and gently shaken on an orbital shaker at room temperature for 30 minutes. Tubes were
then centrifuged (8000 x g for 5 minutes) and the supernatants drained and discarded.
Additional tapping onto an absorbent paper towel ensured the removal of all dye solution.
The collagen bound dye remained as a pellet at the bottom of the tubes. Addition of 1 ml
of Alkali reagent was now added to each tube and brought into solution using a vortex
mixer and two short mixing periods. Aliquots of 100ul were plated onto a 96-well plate
and the absorbance was measured at a wavelength of 530 nm using a microplate reader
(TECAN, NC). A calibration standard of acid-soluble type I collagen was used to obtain
the standard curve for this experiment. ECM contents were normalized to the wet mass
of the new tissues for all assays.
Experimental Protocol
Organizing experiments is an iterative process that ultimately leads to
optimization of the parameters necessary for identifying engineered tissue characteristics.
Preliminary experiments were done to determine parameters for seeding
conditions and optimization of cell attachment to the polymer fibers. Polymer mesh was
cut into a disc, 1cm in diameter and placed in a 25cm 3 culture flask containing a cell
suspension of 20,000 HMVELC cells. Very little attachment was seen after 1 day when
analyzed using a phase contrast microscope. Most cells had adhered to the bottom of the
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flask and not the scaffold. These results lead to the development of a hydrolysis protocol
to improve attachment to the polymer scaffold.
Further experiments were carried out to characterize polymer degradation and
properties of engineered tissue constructs. Initially, multiple samples were analyzed over
time periods of up to 10 days. Bioreactor conditions ultimately determined the number of
samples that we could culture for analysis. Multiple samples were grown for each type of
characterization. This required that the same parameters were established to eliminate
experimental variations.
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APPENDIX C
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Elastic Modulus Data and Welch's t-tests
org h yd treat imrg0 2 00
176651 346324 367570 946352 88027 58650 42412 87294 309052
181309 245858 264376 134880 57473 70152 94443 121423 221161
I _ J[344697 391135 88999 52392 59115 48091 96396
156664 301955 64005 59161 121614 96757
0 
_[69979 51831 107006 61504 460543
S ] h t [ 23 4 1[ 7 imrI ] X ][ A | R R R ]R ][R A ]~A
Ih][ A ][ X A R R ][R R ][A ][A
ltI[ R |[ A I[ X R ]IR R ][R ][A ] A[ _ ] R 1[ R )[ R || X ]I A ] A ]j A I A ]~ A
3][ R || R |R ]| A ]| X A R ]A A
4 ||] R i| R ]| R ]I A ]| A X A A 11 A ][ 5 ]| R if R ][ R A R|1R A II X I A I A ][ 7 || A || A ]| A A| A A X J[imr ||A if A ]j A ]I A [| All Al A ~lA iX
82
Elastic Modulus Welch's t-tests
ACCEPT ACCEPT
O H H T
Mean 178980 273385.8 Mean 273385.8 331259
Variance 10848482 8.26E+09 Variance 8.26E+09 3.41 E+09
Observatio 2 4 Observatio 4 4
Hypothesiz 0 Hypothesiz 0
df 3 df 5
t Stat -2.074471 t Stat -1.071257
P(T<=t) on 0.064843 P(T<=t) on 0.166508
t Critical or 2.353363 t Critical or 2.015049
P(T<=t) tw< 0.129686 P(T<=t) tw< 0.333016
t Critical tw 3.182449 t Critical tw 2.570578
ACCEPT ACCEPT
O IMR 7 IMR
Mean 178980 390077 Mean 198151.2 390077
Variance 10848482 2.33E+11 Variance 4.01E+10 2.33E+11
Observatio 2 3 Observatio 5 3
Hypothesiz 0 Hypothesiz 0
df 2 df 2
t Stat -0.758081 t Stat -0.656195
P(T<=t) on 0.263776 P(T<=t) on 0.289551
t Critical or 2.919987 t Critical or 2.919987
P(T<=t) tw( 0.527553 P(T<=t) tw< 0.579102
t Critical tw 4.302656 t Critical tw 4.302656
ACCEPT ACCEPT
T IMR H IMR
Mean 331259 390077 Mean 273385.8 390077
Variance 3.41E+09 2.33E+11 Variance 8.26E+09 2.33E+11
Observatio 4 3 Observatio 4 3
Hypothesiz 0 Hypothesiz 0
df 2 df 2
t Stat -0.210079 t Stat -0.413597
P(T<=t) on 0.426532 P(T<=t) on 0.35965
t Critical or 2.919987 t Critical or 2.919987
P(T<=t) twc 0.853064 P(T<=t) tw( 0.719301
t Critical tw 4.302656 t Critical tw 4.302656
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REJECT REJECT
0 4 O 3
Mean 178980 82713.2 Mean 178980 59781.8
Variance 10848482 1.27E+09 Variance 10848482 43216814
Observatio 2 5 Observatio 2 5
Hypothesiz 0 Hypothesiz 0
df 4 df 4
t Stat 5.986139 t Stat 31.78042
P(T<=t) on 0.001958 P(T<=t) on 2.92E-06
t Critical or 2.131846 t Critical or 2.131846
P(T<=t) twc 0.003916 P(T<=t) tw< 5.84E-06
t Critical tw 2.776451 t Critical tw 2.776451
REJECT REJECT
H 4 H 5
Mean 273385.8 82713.2 Mean 273385.8 92674.8
Variance 8.26E+09 1.27E+09 Variance 8.26E+09 4.64E+08
Observatio 4 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 4 df 3
t Stat 3.959665 t Stat 3.889665
P(T<=t) on 0.008341 P(T<=t) on 0.015064
t Critical or 2.131846 t Critical or 2.353363
P(T<=t) tw< 0.016682 P(T<=t) tw< 0.030128
t Critical tw 2.776451 t Critical tw 3.182449
REJECT REJECT
T 4 T 3
Mean 331259 82713.2 Mean 331259 59781.8
Variance 3.41E+09 1.27E+09 Variance 3.41E+09 43216814
Observatio 4 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 5 df 3
t Stat 7.473016 t Stat 9.248605
P(T<=t) on 0.000339 P(T<=t) on 0.001337
t Critical or 2.015049 t Critical or 2.353363
P(T<=t) tw< 0.000678 P(T<=t) tw< 0.002675
t Critical tw 2.570578 t Critical tw 3.182449
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ACCEPT ACCEPT
2 5 2 7
Mean 66375.2 92674.8 Mean 66375.2 198151.2
Variance 1.91E+08 4.64E+08 Variance 1.91E+08 4.01E+10
Observatio 5 5 Observatio 5 5
Hypothesiz 0 Hypothesiz 0
df 7 df 4
t Stat -2.297926 t Stat -1.468864
P(T<=t) on 0.02758 P(T<=t) on 0.107898
t Critical or 1.894578 t Critical or 2.131846
P(T<=t) tw< 0.055159 P(T<=t) twc 0.215796
t Critical tw 2.364623 t Critical tw 2.776451
ACCEPT ACCEPT
5 4 4 7
Mean 92674.8 82713.2 Mean 82713.2 198151.2
Variance 4.64E+08 1.27E+09 Variance 1.27E+09 4.01 E+10
Observatio 5 5 Observatio 5 5
Hypothesiz 0 Hypothesiz 0
df 7 df 4
t Stat 0.535484 t Stat -1.269894
P(T<=t) on 0.30445 P(T<=t) on 0.136485
t Critical or 1.894578 t Critical or 2.131846
P(T<=t) tw< 0.608899 P(T<=t) tw< 0.27297
t Critical tw 2.364623 t Critical tw 2.776451
ACCEPT REJECT
3 IMR O T
Mean 59781.8 390077 Mean 331259 178980
Variance 43216814 2.33E+11 Variance 3.41E+09 10848482
Observatio 5 3 Observatio 4 2
Hypothesiz 0 Hypothesiz 0
df 2 df 3
t Stat -1.186115 t Stat 5.197514
P(T<=t) on 0.178694 P(T<=t) on 0.006918
t Critical or 2.919987 t Critical or 2.353363
P(T<=t) tw< 0.357388 P(T<=t) twc 0.013837
t Critical tw 4.302656 t Critical tw 3.182449
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ACCEPT ACCEPT
5 IMR 4 IMR
Mean 92674.8 390077 Mean 82713.2 390077
Variance 4.64E+08 2.33E+11 Variance 1.27E+09 2.33E+11
Observatio 5 3 Observatio 5 3
Hypothesiz 0 Hypothesiz 0
df 2 df 2
t Stat -1.067414 t Stat -1.10203
P(T<=t) on 0.198782 P(T<=t) on 0.192667
t Critical or 2.919987 t Critical or 2.919987
P(T<=t) tw( 0.397563 P(T<=t) tw< 0.385335
t Critical tw 4.302656 t Critical tw 4.302656
REJECT ACCEPT
O 2 O 7
Mean 178980 66375.2 Mean 178980 198151.2
Variance 10848482 1.91E+08 Variance 10848482 4.01E+10
Observatio 2 5 Observatio 2 5
Hypothesiz 0 Hypothesiz 0
df 5 df 4
t Stat 17.06653 t Stat -0.21413
P(T<=t) on 6.32E-06 P(T<=t) on 0.420459
t Critical or 2.015049 t Critical or 2.131846
P(T<=t) twc 1.26E-05 P(T<=t) twc 0.840918
t Critical tw 2.570578 t Critical tw 2.776451
REJECT REJECT
H 3 H 2
Mean 273385.8 59781.8 Mean 273385.8 66375.2
Variance 8.26E+09 43216814 Variance 8.26E+09 1.91E+08
Observatio 4 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 3 df 3
t Stat 4.690087 t Stat 4.513372
P(T<=t) on 0.009163 P(T<=t) on 0.010164
t Critical or 2.353363 t Critical or 2.353363
P(T<=t) twc 0.018325 P(T<=t) tw< 0.020328
t Critical tw 3.182449 t Critical tw 3.182449
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ACCEPT ACCEPT
H 7 T 7
Mean 273385.8 198151.2 Mean 331259 198151.2
Variance 8.26E+09 4.01E+10 Variance 3.41E+09 4.01E+10
Observatio 4 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 6 df 5
t Stat 0.749508 t Stat 1.413861
P(T<=t) on 0.240947 P(T<=t) on 0.108267
t Critical or 1.943181 t Critical or 2.015049
P(T<=t) twc 0.481893 P(T<=t) tw< 0.216535
t Critical tw 2.446914 t Critical tw 2.570578
REJECT ACCEPT
T 2 2 3
Mean 331259 66375.2 Mean 66375.2 59781.8
Variance 3.41E+09 1.91E+08 Variance 1.91E+08 43216814
Observatio 4 5 Observatio 5 5
Hypothesiz 0 Hypothesiz 0
df 3 df 6
t Stat 8.873528 t Stat 0.964288
P(T<=t) on 0.001509 P(T<=t) on 0.186071
t Critical or 2.353363 t Critical or 1.943181
P(T<=t) tw< 0.003018 P(T<=t) tw 0.372141
t Critical tw 3.182449 t Critical tw 2.446914
ACCEPT REJECT
3 4 5 3
Mean 59781.8 82713.2 Mean 92674.8 59781.8
Variance 43216814 1.27E+09 Variance 4.64E+08 43216814
Observatio 5 5 Observatio 5 5
Hypothesiz 0 Hypothesiz 0
df 4 df 5
t Stat -1.417146 t Stat 3.264575
P(T<=t) on 0.114701 P(T<=t) on 0.011166
t Critical or 2.131846 t Critical or 2.015049
P(T<=t) tw( 0.229403 P(T<=t) tw< 0.022332
t Critical tw 2.776451 t Critical tw 2.570578
87
ACCEPT ACCEPT
3 7 5 7
Mean 59781.8 198151.2 Mean 92674.8 198151.2
Variance 43216814 4.01E+10 Variance 4.64E+08 4.01E+10
Observatio 5 5 Observatio 5 5
Hypothesiz 0 Hypothesiz 0
df 4 df 4
t Stat -1.54519 t Stat -1.171731
P(T<=t) on 0.098595 P(T<=t) on 0.153167
t Critical or 2.131846 t Critical or 2.131846
P(T<=t) tw 0.197191 P(T<=t) twc 0.306335
t Critical tw 2.776451 t Critical tw 2.776451
ACCEPT ACCEPT
2 IMR 2 4
Mean 66375.2 390077 Mean 66375.2 82713.2
Variance 1.91 E+08 2.33E+11 Variance 1.91 E+08 1.27E+09
Observatio 5 3 Observatio 5 5
Hypothesiz 0 Hypothesiz 0
df 2 df 5
t Stat -1.162216 t Stat -0.957252
P(T<=t) on 0.182542 P(T<=t) on 0.191201
t Critical or 2.919987 t Critical or 2.015049
P(T<=t) tw< 0.365084 P(T<=t) tw< 0.382403
t Critical tw 4.302656 t Critical tw 2.570578
REJECT REJECT
O 5 T 5
Mean 178980 92674.8 Mean 331259 92674.8
Variance 10848482 4.64E+08 Variance 3.41 E+09 4.64E+08
Observatio 2 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 4 df 4
t Stat 8.704768 t Stat 7.757653
P(T<=t) on 0.00048 P(T<=t) on 0.000744
t Critical or 2.131846 t Critical or 2.131846
P(T<=t) tw 0.000959 P(T<=t) tw< 0.001488
t Critical tw 2.776451 t Critical tw 2.776451
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Yield Stress Data and Welch's t-test Results
org .s. h d s treat .s. imr90 .s. 5da ys 4da s 2das 3da s 7dayys
131681 211817 323161 55057 55552 38945 48335 25329 52164
124506 234863 179282 8614 46992 42643 26936 35682 63323
301506 409560 13021 44247 25761|[ 37362 38265E19775
II 160742[ 197675|[ || 59482 42877[ 20872 27002 18696
II 1I 34478 46341 32200 39607 73072
__ org 1 hyd ]f treat ][ 2 ®3 0 4 5 7 IMR9O
org x a a r I[ 1[ r r r[ hyd ]I|a x ]| a lE r || r || r r r r
treatl a || a l|x I( r J[ r r II r I r r
[2 r]|i1 r r ]l r x 1[|| ] r r r 'a
[3 ] r || r ]l r E| r ][ x~] r r Er a I[ 4 r[ J | r || r j[ r r ]r x r [ ra[ 5 |[r J[ r ]l r l[ r || r r x IF r a[ 7 || r |[ r ]I r j[ r ]| r r r II x II a
imr9O |[ r || r | r J[ a]|[ all| al| a ]I a x
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Yield-Stress Welch's t-test results
accept reject
org h yd hyd imr90
Mean 128093.5 227232 Mean 227232 25564
Variance 25740313 3.41E+09 Variance 3.41E+09 6.57E+08
Observatio 2 4 Observatio 4 3
Hypothesiz 0 Hypothesiz 0
df 3 df 4
t Stat -3.369537 t Stat 6.159816
P(T<=t) on 0.021713 P(T<=t) on 0.001763
t Critical or 2.353363 t Critical or 2.131846
P(T<=t) tw< 0.043426 P(T<=t) tw< 0.003525
t Critical tw 3.182449 t Critical tw 2.776451
accept reject
org treat treat imr90
Mean 128093.5 277419.5 Mean 277419.5 25564
Variance 25740313 1.18E+10 Variance 1.18E+10 6.57E+08
Observatio 2 4 Observatio 4 3
Hypothesiz 0 Hypothesiz 0
df 3 df 3
t Stat -2.737815 t Stat 4.465467
P(T<=t) on 0.035735 P(T<=t) on 0.010459
t Critical or 2.353363 t Critical or 2.353363
P(T<=t) tw< 0.071469 P(T<=t) tw< 0.020919
t Critical tw 3.182449 t Critical tw 3.182449
accept reject
hyd treat org 5day
Mean 128093.5 277419.5 Mean 128093.5 48150.2
Variance 25740313 1.18E+10 Variance 25740313 96675446
Observatio 2 4 Observatio 2 5
Hypothesiz 0 Hypothesiz 0
df 3 df 4
t Stat -2.737815 t Stat 14.08701
P(T<=t) on 0.035735 P(T<=t) on 7.37E-05
t Critical or 2.353363 t Critical or 2.131846
P(T<=t) tw< 0.071469 P(T<=t) tw< 0.000147
t Critical tw 3.182449 t Critical tw 2.776451
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reject reject
org imr9o hyd 3day
Mean 128093.5 25564 Mean 227232 33177
Variance 25740313 6.57E+08 Variance 3.41 E+09 43307350
Observatio 2 3 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 2 df 3
t Stat 6.732148 t Stat 6.611669
P(T<=t) on 0.01068 P(T<=t) on 0.003522
t Critical or 2.919987 t Critical or 2.353363
P(T<=t) tw 0.02136 P(T<=t) tw< 0.007045
t Critical tw 4.302656 t Critical tw 3.182449
reject accept
hyd 4day 3day imr
Mean 227232 39313.4 Mean 33177 25564
Variance 3.41 E+09 64243977 Variance 43307350 6.57E+08
Observatio 4 5 Observatio 5 3
Hypothesiz 0 Hypothesiz 0
df 3 df 2
t Stat 6.38709 t Stat 0.504472
P(T<=t) on 0.003886 P(T<=t) on 0.33201
t Critical or 2.353363 t Critical or 2.919987
P(T<=t) tw< 0.007772 P(T<=t) tw< 0.664021
t Critical tw 3.182449 t Critical tw 4.302656
accept reject
2day imr treat 7day
Mean 33141 25564 Mean 277419.5 45406
Variance 1.1E+08 6.57E+08 Variance 1.18E+10 6.26E+08
Observatio 5 3 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 2 df 3
t Stat 0.48807 t Stat 4.175792
P(T<=t) on 0.336882 P(T<=t) on 0.012506
t Critical or 2.919987 t Critical or 2.353363
P(T<=t) tw< 0.673764 P(T<=t) tw< 0.025012
t Critical tw 4.302656 t Critical tw 3.182449
91
accept reject
5day imr9o hyd 2day
Mean 48150.2 25564 Mean 227232 33141
Variance 96675446 6.57E+08 Variance 3.41 E+09 1.1E+08
Observatio 5 3 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 2 df 3
t Stat 1.462778 t Stat 6.56255
P(T<=t) on 0.14053 P(T<=t) on 0.003598
t Critical or 2.919987 t Critical or 2.353363
P(T<=t) tw 0.28106 P(T<=t) tw( 0.007196
t Critical tw 4.302656 t Critical tw 3.182449
reject reject
org 2day org 3day
Mean 128093.5 33141 Mean 128093.5 33177
Variance 25740313 1.1E+08 Variance 25740313 43307350
Observatio 2 5 Observatio 2 5
Hypothesiz 0 Hypothesiz 0
df 4 df 3
t Stat 16.09603 t Stat 20.45518
P(T<=t) on 4.36E-05 P(T<=t) on 0.000128
t Critical or 2.131846 t Critical or 2.353363
P(T<=t) tw< 8.71 E-05 P(T<=t) tw< 0.000255
t Critical tw 2.776451 t Critical tw 3.182449
reject accept
org 7day 7day imr9o
Mean 128093.5 45406 Mean 45406 25564
Variance 25740313 6.26E+08 Variance 6.26E+08 6.57E+08
Observatio 2 5 Observatio 5 3
Hypothesiz 0 Hypothesiz 0
df 5 df 4
t Stat 7.03899 t Stat 1.069496
P(T<=t) on 0.000447 P(T<=t) on 0.172545
t Critical or 2.015049 t Critical or 2.131846
P(T<=t) twc 0.000894 P(T<=t) twc 0.345091
t Critical tw 2.570578 t Critical tw 2.776451
92
reject reject
hyd 5day hyd 7day
Mean 227232 48150.2 Mean 227232 45406
Variance 3.41 E+09 96675446 Variance 3.41 E+09 6.26E+08
Observatio 4 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 3 df 4
t Stat 6.064063 t Stat 5.814431
P(T<=t) on 0.0045 P(T<=t) on 0.002178
t Critical or 2.353363 t Critical or 2.131846
P(T<=t) tw< 0.008999 P(T<=t) tw( 0.004355
t Critical tw 3.182449 t Critical tw 2.776451
reject reject
treat 3day treat 4day
Mean 277419.5 33177 Mean 277419.5 39313.4
Variance 1.18E+10 43307350 Variance 1.18E+10 64243977
Observatio 4 5 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 3 df 3
t Stat 4.481232 t Stat 4.365568
P(T<=t) on 0.010361 P(T<=t) on 0.011113
t Critical or 2.353363 t Critical or 2.353363
P(T<=t) tw( 0.020722 P(T<=t) twc 0.022225
t Critical tw 3.182449 t Critical tw 3.182449
accept reject
4day imr treat 2day
Mean 39313.4 25564 Mean 277419.5 33141
Variance 64243977 6.57E+08 Variance 1.18E+10 1.1E+08
Observatio 5 3 Observatio 4 5
Hypothesiz 0 Hypothesiz 0
df 2 df 3
t Stat 0.902835 t Stat 4.471917
P(T<=t) on 0.230951 P(T<=t) on 0.010419
t Critical or 2.919987 t Critical or 2.353363
P(T<=t) tw< 0.461903 P(T<=t) tw< 0.020838
t Critical tw 4.302656 t Critical tw 3.182449
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reject reject
treat 5day org 4day
Mean 277419.5 48150.2 Mean 128093.5 39313.4
Variance 1.18E+10 96675446 Variance 25740313 64243977
Observatio 4 5 Observatio 2 5
Hypothesiz 0 Hypothesiz 0
df 3 df 3
t Stat 4.198974 t Stat 17.50608
P(T<=t) on 0.012324 P(T<=t) on 0.000203
t Critical or 2.353363 t Critical or 2.353363
P(T<=t) twc 0.024648 P(T<=t) tw< 0.000406
t Critical tw 3.182449 t Critical tw 3.182449
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